Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Provided By GlobeNewswire
Last update: Apr 1, 2025
CHARLESTOWN, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 43,374 restricted stock units (“RSUs”) to three newly hired employees.
Read more at globenewswire.com
